Harvard Gazette: Chemistry and Chemical Biology fellowships awarded

HOME : On Campus

Prev issues | Contact us | Harvard News Office

Current Issue:
April 05, 2001

News, events, features

Latest scientific findings

The people behind the university

Harvard and neighbor communities

Scores, highlights, upcoming games

On Campus

Newsmakers, notes, students, police log

Museums, concerts, theater

Two-week listing of upcoming events

HARVARD GAZETTE ARCHIVES

Chemistry and Chemical Biology fellowships awarded

Each year, the Department of Chemistry and Chemical Biology receives a number of corporate fellowships instrumental in the training of graduate students in organic chemistry. The 2000-01 research fellowships are sponsored by Eli Lilly Research Laboratories, Hoffmann-La Roche Inc., and Bristol-Myers Squibb Pharmaceutical Research. Ten graduate students have been awarded the fellowships this year.

Eli Lilly Pre-doctoral Fellowships

Eli Lilly is a global research-based pharmaceutical company that has marketed several drugs for the treatment of cancer, schizophrenia, osteoporosis, diabetes, depression, and cardiovascular complications. Eli Lilly has recently increased its annual support to $150,000, and has given the department of chemistry graduate fellowship support since 1991. The 2000-01 Eli Lilly Pre-doctoral Fellowship recipients are David Barnes-Seeman, Jeffrey Johannes, Joseph Ready, Ryan Spoering, and Michael Storek.

Roche Fellowships

Hoffmann-La Roche is involved in the therapeutic areas of oncology; metabolic diseases, including obesity and diabetes; virology, including HIV; influenza and hepatitis C; as well as inflammation/autoimmune, vascular, and genitourinary diseases. In 1997, the company established a five-year fellowship with the chemistry department, which provides $100,000 annually for organic synthesis research of five graduate students.

The Roche Fellows for 2000-01 are Anirban Banerjee, Carl Morales, Mohammad Movassaghi, Gretchen Peterson, and Scott Sternson.

Bristol-Myers Squibb Fellowships in Synthetic Organic Chemistry

The Bristol-Myers Squibb Pharmaceutical Research Institute's research portfolio spans therapeutic areas in oncology, cardiovascular disease, metabolic disease, infectious disease, immunology/inflammation, neuroscience, pain management, dermatological disease, and pulmonary disease. In 1998, the company awarded the department a three-year fellowship of $38,000 annually for research in organic synthesis and an annual symposium. Krista Beaver Goodman is the third Bristol-Myers Squibb Graduate Fellow.